EPISODE · Jan 10, 2022 · 14 MIN
Induction and Maintenance Therapy for Fit Patients With AML Without Targetable Mutations
from Decera Clinical Education Oncology Podcast · host Ashley Leak Bryant PhD RN OCN FAAN
In this podcast episode, Ashley Leak Bryant, PhD, RN, OCN, FAAN, discusses therapeutic options for younger, fit patients with AML and no targetable mutations. Topics include:Induction chemotherapy and consolidation therapyUse of gemtuzumab ozogamicinManagement of sinusoidal obstruction syndrome Nursing considerations for younger, fit patients with AMLPresenter:Ashley Leak Bryant, PhD, RN, OCN, FAANAssociate ProfessorSchool of NursingUNC Lineberger Comprehensive Cancer Center University of North Carolina at Chapel HillChapel Hill, North Carolina Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
What this episode covers
In this podcast episode, Ashley Leak Bryant, PhD, RN, OCN, FAAN, discusses treatment strategies for fit patients with AML without targetable mutations.
NOW PLAYING
Induction and Maintenance Therapy for Fit Patients With AML Without Targetable Mutations
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Jan 2, 2026 ·47m
Dec 21, 2025 ·46m